
IRIDEX Corporation is a medical devices business based in the US. IRIDEX Corporation shares (IRIX) are listed on the NASDAQ and all prices are listed in US Dollars. IRIDEX Corporation employs 119 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in IRIDEX Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IRIX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

IRIDEX Corporation stock price (NASDAQ: IRIX)
Use our graph to track the performance of IRIX stocks over time.IRIDEX Corporation shares at a glance
Latest market close | $2.47 |
---|---|
52-week range | $2.48 - $9.46 |
50-day moving average | $3.20 |
200-day moving average | $5.34 |
Wall St. target price | $9.75 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.36 |
Buy IRIDEX Corporation shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy IRIDEX Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
IRIDEX Corporation price performance over time
Historical closes compared with the close of $2.47 from 2022-07-01
1 week (2022-06-24) | -9.85% |
---|---|
1 month (2022-06-03) | -14.83% |
3 months (2022-03-30) | N/A |
6 months (2022-01-03) | -61.53% |
1 year (2021-07-02) | -65.31% |
---|---|
2 years (2020-07-02) | 14.35% |
3 years (2019-07-03) | 4.13 |
5 years (2017-07-03) | 9.61 |
IRIDEX Corporation financials
Revenue TTM | $55.3 million |
---|---|
Gross profit TTM | $22.8 million |
Return on assets TTM | -10.21% |
Return on equity TTM | -23.87% |
Profit margin | -10.13% |
Book value | $1.34 |
Market capitalisation | $40.8 million |
TTM: trailing 12 months
IRIDEX Corporation share dividends
We're not expecting IRIDEX Corporation to pay a dividend over the next 12 months.
IRIDEX Corporation share price volatility
Over the last 12 months, IRIDEX Corporation's shares have ranged in value from as little as $2.48 up to $9.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRIDEX Corporation's is 1.2564. This would suggest that IRIDEX Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
IRIDEX Corporation overview
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc.
IRIDEX Corporation in the news
Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in China
Frequently asked questions
What percentage of IRIDEX Corporation is owned by insiders or institutions?Currently 30.86% of IRIDEX Corporation shares are held by insiders and 27.137% by institutions. How many people work for IRIDEX Corporation?
Latest data suggests 119 work at IRIDEX Corporation. When does the fiscal year end for IRIDEX Corporation?
IRIDEX Corporation's fiscal year ends in December. Where is IRIDEX Corporation based?
IRIDEX Corporation's address is: 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043 What is IRIDEX Corporation's ISIN number?
IRIDEX Corporation's international securities identification number is: US4626841013 What is IRIDEX Corporation's CUSIP number?
IRIDEX Corporation's Committee on Uniform Securities Identification Procedures number is: 462684101
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert